Enzymotec Ltd (ENZY) 6.71 $ENZY
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Tue Oct 21, 11:52AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 6.71 (+0.16)
Billionaires' Bad Bets: Their Worst Performing Stocks in 2014
at The Street - Mon Oct 20, 11:46AM CDT
See the stocks that have performed the worst for 19 billionaires who made their money investing.
BID: 38.44 (-0.28), CBI: 50.79 (-0.53), MDR: 4.33 (+0.12), DLIA: 0.15 (unch), EOPN: 5.72 (-0.09), PGEM: 10.74 (-0.01), ENZY: 6.71 (+0.16), GNC: 40.66 (+0.97), AMCC: 6.77 (-0.13), HHC: 142.23 (+1.50), LL: 52.10 (-5.53), VLTC: 1.45 (+0.02), CZR: 11.80 (-0.64), SNSS: 1.42 (-0.05), TWER: 1.15 (-0.02), SHOS: 14.63 (+0.10), DRYS: 2.09 (-0.02), CREE: 28.50 (-4.65)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Thu Oct 16, 9:32AM CDT
Law Offices of Howard G. Smith reminds investors that purchasers of the securities of Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.
ENZY: 6.71 (+0.16)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
PR Newswire - Mon Oct 06, 1:33PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq: ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014.
ENZY: 6.71 (+0.16)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Enzymotec Ltd. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ENZY
GlobeNewswire - Sat Oct 04, 7:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents" issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" .
ENZY: 6.71 (+0.16)
ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Fri Oct 03, 5:22PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq: ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey.
ENZY: 6.71 (+0.16)
EQUITY ALERT: The Rosen Law Firm Reminds Enzymotec Ltd. Investors of Important Class Action Deadline -- ENZY
GlobeNewswire - Thu Oct 02, 1:13PM CDT
The Rosen Law Firm reminds purchasers of Enzymotec Ltd. securities (Nasdaq:ENZY) during the period from September 27, 2013 through August 4, 2014, of the important November 4, 2014 class action deadline.
ENZY: 6.71 (+0.16)
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Enzymotec Ltd.
GlobeNewswire - Tue Sep 30, 3:01PM CDT
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Enzymotec Ltd. ("Enzymotec" or the "Company" and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 or violated the Securities Act of 1933.
ENZY: 6.71 (+0.16)
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Enzymotec Ltd. (ENZY) To Contact The Firm
PR Newswire - Fri Sep 26, 6:30PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ: ENZY) of the November 4, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Enzymotec, certain executives and directors of Enzymotec, and the underwriters of the Company's initial public offering.
ENZY: 6.71 (+0.16)
ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Tue Sep 23, 9:00PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq:ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey.
ENZY: 6.71 (+0.16)
INVESTOR ALERT: Class Action Lawsuit Against Enzymotec Ltd. Announced by Law Offices of Howard G. Smith
Business Wire - Tue Sep 23, 9:32AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of purchasers of the securities of Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" .
ENZY: 6.71 (+0.16)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Enzymotec Ltd. To Contact Brower Piven Before The November 4, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Mon Sep 22, 12:04PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq: ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents" issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" .
ENZY: 6.71 (+0.16)
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Enzymotec Ltd. - ENZY
PR Newswire - Fri Sep 19, 10:50AM CDT
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action has been filed against Enzymotec Ltd. (Nasdaq: ENZY) ("Enzymotec" or "the Company" on behalf of purchasers of the Company's common stock issued pursuant and/or traceable to Enzymotec's Initial Public Offering (the "IPO" on or about September 27, 2013 through August 4, 2014, inclusive (the "Class Period" .
ENZY: 6.71 (+0.16)
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Thu Sep 18, 8:12AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
MBII: 2.92 (-0.14), IRMD: 7.40 (+0.16), SEAS: 18.46 (+0.40), MGAM: 33.89 (+0.48), ENZY: 6.71 (+0.16), FUEL: 17.21 (-0.02), FBC: 16.10 (-0.68), CVLT: 48.38 (-0.09)
SHAREHOLDER ALERT: Investigation on Behalf of Enzymotec Ltd. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Tue Sep 16, 8:32PM CDT
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Enzymotec Ltd. ("Enzymotec" or the "Company" (NASDAQ:ENZY) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by Enzymotec concerning the Company's business, operations and financial prospects. Enzymotec develops, manufactures and markets bio-active lipid ingredients used in the production of various nutritional products. The Company's primary source of revenue is through its baby formula business, including the popular InFat line of products.
ENZY: 6.71 (+0.16)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Thu Sep 11, 3:42PM CDT
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company" (Nasdaq:ENZY) securities between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" .
ENZY: 6.71 (+0.16)
Robbins Arroyo LLP: Enzymotec Ltd. (ENZY) Stock Falls Nearly 40% After Violations of Federal Law are Revealed, According to Class Action
GlobeNewswire - Wed Sep 10, 7:37PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Enzymotec Ltd. (Nasdaq:ENZY) has filed a federal securities class action complaint in the U.S. District Court for the District of New Jersey. The complaint alleges that the company and certain of its officers and directors violated the Securities Act of 1933 and the Securities Exchange Act of 1934 in connection with the company's initial public offering on September 27, 2013. Enzymotec develops, manufactures, and markets innovative bio-active lipid ingredients used in various nutritional products.
ENZY: 6.71 (+0.16)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014
Business Wire - Tue Oct 21, 11:52AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq:ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014. ENZY: 6.71 (+0.16)
Billionaires' Bad Bets: Their Worst Performing Stocks in 2014
at The Street - Mon Oct 20, 11:46AM CDT
See the stocks that have performed the worst for 19 billionaires who made their money investing.
BID: 38.44 (-0.28), CBI: 50.79 (-0.53), MDR: 4.33 (+0.12), DLIA: 0.15 (unch), EOPN: 5.72 (-0.09), PGEM: 10.74 (-0.01), ENZY: 6.71 (+0.16), GNC: 40.66 (+0.97), AMCC: 6.77 (-0.13), HHC: 142.23 (+1.50), LL: 52.10 (-5.53), VLTC: 1.45 (+0.02), CZR: 11.80 (-0.64), SNSS: 1.42 (-0.05), TWER: 1.15 (-0.02), SHOS: 14.63 (+0.10), DRYS: 2.09 (-0.02), CREE: 28.50 (-4.65)
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Thu Oct 16, 9:32AM CDT
Law Offices of Howard G. Smith reminds investors that purchasers of the securities of Enzymotec Ltd. ("Enzymotec" or the "Company"
(NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" , have until November 4, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit. ENZY: 6.71 (+0.16)
UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Enzymotec Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of November 4, 2014 -- ENZY
PR Newswire - Mon Oct 06, 1:33PM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq: ENZY) common stock pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or investors who purchased shares on the open market between September 27, 2013 and August 4, 2014. ENZY: 6.71 (+0.16)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Enzymotec Ltd. to Contact Brower Piven Before the November 4, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- ENZY
GlobeNewswire - Sat Oct 04, 7:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq:ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents" issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . ENZY: 6.71 (+0.16)
ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd.
Business Wire - Fri Oct 03, 5:22PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq: ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey. ENZY: 6.71 (+0.16)
EQUITY ALERT: The Rosen Law Firm Reminds Enzymotec Ltd. Investors of Important Class Action Deadline -- ENZY
GlobeNewswire - Thu Oct 02, 1:13PM CDT
The Rosen Law Firm reminds purchasers of Enzymotec Ltd. securities (Nasdaq:ENZY) during the period from September 27, 2013 through August 4, 2014, of the important November 4, 2014 class action deadline.
ENZY: 6.71 (+0.16)
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Enzymotec Ltd.
GlobeNewswire - Tue Sep 30, 3:01PM CDT
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Enzymotec Ltd. ("Enzymotec" or the "Company"
and certain of its officers and directors made false and misleading statements and/or omissions in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 or violated the Securities Act of 1933. ENZY: 6.71 (+0.16)
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Enzymotec Ltd. (ENZY) To Contact The Firm
PR Newswire - Fri Sep 26, 6:30PM CDT
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Enzymotec Ltd. ("Enzymotec" or the "Company"
(NASDAQ: ENZY) of the November 4, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Enzymotec, certain executives and directors of Enzymotec, and the underwriters of the Company's initial public offering. ENZY: 6.71 (+0.16)
ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Tue Sep 23, 9:00PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 4, 2014 to file lead plaintiff applications in a securities class action lawsuit against Enzymotec Ltd. (Nasdaq:ENZY), if they purchased the Company's securities in connection with the Company's initial public offering ("IPO" on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the District of New Jersey. ENZY: 6.71 (+0.16)
INVESTOR ALERT: Class Action Lawsuit Against Enzymotec Ltd. Announced by Law Offices of Howard G. Smith
Business Wire - Tue Sep 23, 9:32AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of purchasers of the securities of Enzymotec Ltd. ("Enzymotec" or the "Company"
(NASDAQ:ENZY) pursuant and/or traceable to the Company's Registration Statement and Prospectus issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . ENZY: 6.71 (+0.16)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Enzymotec Ltd. To Contact Brower Piven Before The November 4, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Mon Sep 22, 12:04PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq: ENZY) securities pursuant and/or traceable to the Company's Registration Statement and Prospectus ("Offering Documents" issued in connection with the Company's initial public offering on or about September 27, 2013, and/or on the open market between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . ENZY: 6.71 (+0.16)
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Enzymotec Ltd. - ENZY
PR Newswire - Fri Sep 19, 10:50AM CDT
The law firm of Kessler Topaz Meltzer & Check, LLP announces that a shareholder class action has been filed against Enzymotec Ltd. (Nasdaq: ENZY) ("Enzymotec" or "the Company"
on behalf of purchasers of the Company's common stock issued pursuant and/or traceable to Enzymotec's Initial Public Offering (the "IPO" on or about September 27, 2013 through August 4, 2014, inclusive (the "Class Period" . ENZY: 6.71 (+0.16)
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Thu Sep 18, 8:12AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
MBII: 2.92 (-0.14), IRMD: 7.40 (+0.16), SEAS: 18.46 (+0.40), MGAM: 33.89 (+0.48), ENZY: 6.71 (+0.16), FUEL: 17.21 (-0.02), FBC: 16.10 (-0.68), CVLT: 48.38 (-0.09)
SHAREHOLDER ALERT: Investigation on Behalf of Enzymotec Ltd. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Tue Sep 16, 8:32PM CDT
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Enzymotec Ltd. ("Enzymotec" or the "Company"
(NASDAQ:ENZY) concerning possible violations of federal securities laws. The investigation focuses on certain statements issued by Enzymotec concerning the Company's business, operations and financial prospects. Enzymotec develops, manufactures and markets bio-active lipid ingredients used in the production of various nutritional products. The Company's primary source of revenue is through its baby formula business, including the popular InFat line of products. ENZY: 6.71 (+0.16)
Morgan & Morgan Announces That a Class Action Lawsuit Has Been Filed Against Enzymotec Ltd. -- ENZY
GlobeNewswire - Thu Sep 11, 3:42PM CDT
Morgan & Morgan announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Enzymotec Ltd. ("Enzymotec" or the "Company"
(Nasdaq:ENZY) securities between September 27, 2013 and August 4, 2014, inclusive (the "Class Period" . ENZY: 6.71 (+0.16)
Robbins Arroyo LLP: Enzymotec Ltd. (ENZY) Stock Falls Nearly 40% After Violations of Federal Law are Revealed, According to Class Action
GlobeNewswire - Wed Sep 10, 7:37PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Enzymotec Ltd. (Nasdaq:ENZY) has filed a federal securities class action complaint in the U.S. District Court for the District of New Jersey. The complaint alleges that the company and certain of its officers and directors violated the Securities Act of 1933 and the Securities Exchange Act of 1934 in connection with the company's initial public offering on September 27, 2013. Enzymotec develops, manufactures, and markets innovative bio-active lipid ingredients used in various nutritional products.
ENZY: 6.71 (+0.16)
